The Effects of Dexmedetomidine on cTnI and GP-BB in Patients Undergoing OPCABG

Coronary Artery Bypass, Off-Pump Clinical Trial

Official title:
The Effects of Dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in Patients Undergoing Off-pump Coronary Artery Bypass Grafting

Status Active, not recruiting

Clinical Trial Summary

The purpose of this study is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients undergoing off-pump coronary artery bypass Grafting.

Clinical Trial Description

Dexmedetomidine is a highly selective α2-adrenoceptor agonist used as a sedative or adjuvant anesthetic drug in clinical settings.From clinical observation, dexmedetomidine has been revealed to reduce the incidence of cardiovascular adverse events in patients with heart diseases during non‑cardiac surgeries.Therefore, the aim of this sudy is to observe the impact of dexmedetomidine on Cardiac Troponin I and Glycogen Phosphorylase Isoenzyme BB in patients during cardiac surgeries. ;

Study Design

Related Conditions & MeSH terms

Coronary Artery Bypass, Off-Pump

Clinical Trial Details

NCT number	NCT03163693
Study type	Interventional
Source	General Hospital of Ningxia Medical University
Contact
Status	Active, not recruiting
Phase	N/A
Start date	February 2016
Completion date	May 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT06399627` - Effect of Non-anemic Iron Deficiency on Outcome Following Off-pump Coronary Revascularization
Completed	`NCT03889730` - Intraoperative Hypotension and Acute Kidney Injury After Off-pump Coronary Artery Bypass Grafting Surgery
Terminated	`NCT02046824` - Cell Savers and Blood Quality	N/A
Recruiting	`NCT03629418` - Targeted Blood-pressure Management and Acute Kidney Injury After Coronary Artery Bypass Surgery	N/A
Recruiting	`NCT04267835` - Prospective Cohort Study on Minimal Invasive Coronary Surgery
Not yet recruiting	`NCT04795193` - Efficacy and Safety of Minimal Invasive Coronary Surgery in Patients With Complex Coronary Artery Lesions	N/A